nodes	percent_of_prediction	percent_of_DWPC	metapath
Glipizide—PPARG—Balsalazide—Crohn's disease	0.403	0.441	CbGbCtD
Glipizide—PPARG—Mesalazine—Crohn's disease	0.322	0.353	CbGbCtD
Glipizide—PPARG—Sulfasalazine—Crohn's disease	0.18	0.197	CbGbCtD
Glipizide—CYP3A4—Prednisone—Crohn's disease	0.00849	0.00929	CbGbCtD
Glipizide—ABCC8—penis—Crohn's disease	0.00721	0.44	CbGeAlD
Glipizide—PPARG—Methyldopa—Mesalazine—Crohn's disease	0.00277	1	CbGdCrCtD
Glipizide—Haematochezia—Mesalazine—Crohn's disease	0.00215	0.0323	CcSEcCtD
Glipizide—Liver injury—Mercaptopurine—Crohn's disease	0.0019	0.0285	CcSEcCtD
Glipizide—Hepatocellular injury—Mercaptopurine—Crohn's disease	0.0016	0.0239	CcSEcCtD
Glipizide—Foetor hepaticus—Mesalazine—Crohn's disease	0.00153	0.0229	CcSEcCtD
Glipizide—Liver disorder—Mesalazine—Crohn's disease	0.00127	0.0191	CcSEcCtD
Glipizide—ABCC8—smooth muscle tissue—Crohn's disease	0.00122	0.0744	CbGeAlD
Glipizide—Liver injury—Azathioprine—Crohn's disease	0.00113	0.017	CcSEcCtD
Glipizide—Jaundice cholestatic—Azathioprine—Crohn's disease	0.00108	0.0162	CcSEcCtD
Glipizide—KCNJ11—lymphoid tissue—Crohn's disease	0.00106	0.0645	CbGeAlD
Glipizide—Liver injury—Mesalazine—Crohn's disease	0.00103	0.0154	CcSEcCtD
Glipizide—Jaundice cholestatic—Mesalazine—Crohn's disease	0.000986	0.0148	CcSEcCtD
Glipizide—PPARG—epithelium—Crohn's disease	0.000966	0.0589	CbGeAlD
Glipizide—Hepatocellular injury—Azathioprine—Crohn's disease	0.000951	0.0143	CcSEcCtD
Glipizide—Pancytopenia—Mercaptopurine—Crohn's disease	0.000951	0.0143	CcSEcCtD
Glipizide—PPARG—smooth muscle tissue—Crohn's disease	0.000931	0.0568	CbGeAlD
Glipizide—PPARG—skin of body—Crohn's disease	0.000919	0.056	CbGeAlD
Glipizide—Aplastic anaemia—Azathioprine—Crohn's disease	0.000893	0.0134	CcSEcCtD
Glipizide—Hepatocellular injury—Mesalazine—Crohn's disease	0.000866	0.013	CcSEcCtD
Glipizide—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.000844	0.0127	CcSEcCtD
Glipizide—PPARG—mammalian vulva—Crohn's disease	0.000838	0.0511	CbGeAlD
Glipizide—Aplastic anaemia—Mesalazine—Crohn's disease	0.000813	0.0122	CcSEcCtD
Glipizide—Cramps of lower extremities—Mesalazine—Crohn's disease	0.000796	0.0119	CcSEcCtD
Glipizide—Hepatic function abnormal—Azathioprine—Crohn's disease	0.00079	0.0119	CcSEcCtD
Glipizide—Hypertonia—Mesalazine—Crohn's disease	0.000759	0.0114	CcSEcCtD
Glipizide—PPARG—lymphoid tissue—Crohn's disease	0.000744	0.0454	CbGeAlD
Glipizide—PPARG—digestive system—Crohn's disease	0.000735	0.0448	CbGeAlD
Glipizide—Eczema—Mesalazine—Crohn's disease	0.0007	0.0105	CcSEcCtD
Glipizide—Libido decreased—Mesalazine—Crohn's disease	0.000678	0.0102	CcSEcCtD
Glipizide—Thirst—Mesalazine—Crohn's disease	0.000661	0.00991	CcSEcCtD
Glipizide—Gastrointestinal haemorrhage—Mesalazine—Crohn's disease	0.000629	0.00943	CcSEcCtD
Glipizide—Leukopenia—Mercaptopurine—Crohn's disease	0.000625	0.00937	CcSEcCtD
Glipizide—Disturbance in sexual arousal—Mesalazine—Crohn's disease	0.000624	0.00936	CcSEcCtD
Glipizide—Migraine—Mesalazine—Crohn's disease	0.000619	0.00929	CcSEcCtD
Glipizide—KCNJ11—lymph node—Crohn's disease	0.000597	0.0364	CbGeAlD
Glipizide—Arthralgia—Mercaptopurine—Crohn's disease	0.000594	0.00891	CcSEcCtD
Glipizide—Abdominal pain upper—Mesalazine—Crohn's disease	0.000574	0.00862	CcSEcCtD
Glipizide—Abdominal discomfort—Azathioprine—Crohn's disease	0.000572	0.00858	CcSEcCtD
Glipizide—Oedema—Mercaptopurine—Crohn's disease	0.000569	0.00854	CcSEcCtD
Glipizide—Pancytopenia—Azathioprine—Crohn's disease	0.000567	0.0085	CcSEcCtD
Glipizide—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000558	0.00837	CcSEcCtD
Glipizide—Anorexia—Mercaptopurine—Crohn's disease	0.000543	0.00814	CcSEcCtD
Glipizide—Abdominal discomfort—Mesalazine—Crohn's disease	0.000521	0.00782	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000519	0.00778	CcSEcCtD
Glipizide—Pancytopenia—Mesalazine—Crohn's disease	0.000516	0.00774	CcSEcCtD
Glipizide—Dysuria—Mesalazine—Crohn's disease	0.000508	0.00763	CcSEcCtD
Glipizide—Hepatobiliary disease—Azathioprine—Crohn's disease	0.000503	0.00755	CcSEcCtD
Glipizide—Agranulocytosis—Azathioprine—Crohn's disease	0.000496	0.00745	CcSEcCtD
Glipizide—Photosensitivity reaction—Mesalazine—Crohn's disease	0.000496	0.00744	CcSEcCtD
Glipizide—Decreased appetite—Mercaptopurine—Crohn's disease	0.000495	0.00743	CcSEcCtD
Glipizide—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.000492	0.00738	CcSEcCtD
Glipizide—Jaundice—Mesalazine—Crohn's disease	0.000472	0.00709	CcSEcCtD
Glipizide—Conjunctivitis—Mesalazine—Crohn's disease	0.000471	0.00707	CcSEcCtD
Glipizide—Sweating—Mesalazine—Crohn's disease	0.000465	0.00697	CcSEcCtD
Glipizide—Hepatobiliary disease—Mesalazine—Crohn's disease	0.000458	0.00688	CcSEcCtD
Glipizide—Agranulocytosis—Mesalazine—Crohn's disease	0.000452	0.00679	CcSEcCtD
Glipizide—Rhinitis—Mesalazine—Crohn's disease	0.000436	0.00654	CcSEcCtD
Glipizide—Hepatitis—Mesalazine—Crohn's disease	0.000435	0.00653	CcSEcCtD
Glipizide—Pharyngitis—Mesalazine—Crohn's disease	0.000432	0.00648	CcSEcCtD
Glipizide—CYP2C9—digestive system—Crohn's disease	0.00043	0.0262	CbGeAlD
Glipizide—Chills—Azathioprine—Crohn's disease	0.000428	0.00643	CcSEcCtD
Glipizide—Arrhythmia—Azathioprine—Crohn's disease	0.000427	0.0064	CcSEcCtD
Glipizide—PPARG—lymph node—Crohn's disease	0.00042	0.0256	CbGeAlD
Glipizide—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00042	0.00629	CcSEcCtD
Glipizide—Eye disorder—Mesalazine—Crohn's disease	0.000407	0.0061	CcSEcCtD
Glipizide—Chills—Mesalazine—Crohn's disease	0.00039	0.00586	CcSEcCtD
Glipizide—Diarrhoea—Mercaptopurine—Crohn's disease	0.00039	0.00585	CcSEcCtD
Glipizide—Ill-defined disorder—Azathioprine—Crohn's disease	0.000386	0.00579	CcSEcCtD
Glipizide—Erythema—Mesalazine—Crohn's disease	0.000379	0.00568	CcSEcCtD
Glipizide—Malaise—Azathioprine—Crohn's disease	0.000375	0.00563	CcSEcCtD
Glipizide—Flatulence—Mesalazine—Crohn's disease	0.000373	0.0056	CcSEcCtD
Glipizide—Leukopenia—Azathioprine—Crohn's disease	0.000372	0.00558	CcSEcCtD
Glipizide—Tension—Mesalazine—Crohn's disease	0.000372	0.00558	CcSEcCtD
Glipizide—Nervousness—Mesalazine—Crohn's disease	0.000368	0.00552	CcSEcCtD
Glipizide—Muscle spasms—Mesalazine—Crohn's disease	0.000364	0.00546	CcSEcCtD
Glipizide—Vomiting—Mercaptopurine—Crohn's disease	0.000362	0.00543	CcSEcCtD
Glipizide—Rash—Mercaptopurine—Crohn's disease	0.000359	0.00539	CcSEcCtD
Glipizide—Dermatitis—Mercaptopurine—Crohn's disease	0.000359	0.00538	CcSEcCtD
Glipizide—Vision blurred—Mesalazine—Crohn's disease	0.000357	0.00535	CcSEcCtD
Glipizide—Tremor—Mesalazine—Crohn's disease	0.000355	0.00532	CcSEcCtD
Glipizide—Arthralgia—Azathioprine—Crohn's disease	0.000354	0.00531	CcSEcCtD
Glipizide—Myalgia—Azathioprine—Crohn's disease	0.000354	0.00531	CcSEcCtD
Glipizide—Ill-defined disorder—Mesalazine—Crohn's disease	0.000351	0.00527	CcSEcCtD
Glipizide—Discomfort—Azathioprine—Crohn's disease	0.00035	0.00525	CcSEcCtD
Glipizide—Malaise—Mesalazine—Crohn's disease	0.000341	0.00512	CcSEcCtD
Glipizide—Vertigo—Mesalazine—Crohn's disease	0.00034	0.0051	CcSEcCtD
Glipizide—Syncope—Mesalazine—Crohn's disease	0.00034	0.0051	CcSEcCtD
Glipizide—Leukopenia—Mesalazine—Crohn's disease	0.000339	0.00509	CcSEcCtD
Glipizide—Nausea—Mercaptopurine—Crohn's disease	0.000338	0.00508	CcSEcCtD
Glipizide—Loss of consciousness—Mesalazine—Crohn's disease	0.000333	0.00499	CcSEcCtD
Glipizide—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.000333	0.00499	CcSEcCtD
Glipizide—Thrombocytopenia—Azathioprine—Crohn's disease	0.000332	0.00498	CcSEcCtD
Glipizide—CYP3A4—digestive system—Crohn's disease	0.000328	0.02	CbGeAlD
Glipizide—Hypertension—Mesalazine—Crohn's disease	0.000327	0.00491	CcSEcCtD
Glipizide—Arthralgia—Mesalazine—Crohn's disease	0.000322	0.00484	CcSEcCtD
Glipizide—Myalgia—Mesalazine—Crohn's disease	0.000322	0.00484	CcSEcCtD
Glipizide—Anxiety—Mesalazine—Crohn's disease	0.000321	0.00482	CcSEcCtD
Glipizide—Discomfort—Mesalazine—Crohn's disease	0.000319	0.00478	CcSEcCtD
Glipizide—Confusional state—Mesalazine—Crohn's disease	0.000312	0.00468	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000309	0.00464	CcSEcCtD
Glipizide—Oedema—Mesalazine—Crohn's disease	0.000309	0.00464	CcSEcCtD
Glipizide—Shock—Mesalazine—Crohn's disease	0.000304	0.00456	CcSEcCtD
Glipizide—Thrombocytopenia—Mesalazine—Crohn's disease	0.000303	0.00454	CcSEcCtD
Glipizide—Hyperhidrosis—Mesalazine—Crohn's disease	0.000299	0.00448	CcSEcCtD
Glipizide—Anorexia—Mesalazine—Crohn's disease	0.000295	0.00442	CcSEcCtD
Glipizide—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000293	0.0044	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000282	0.00422	CcSEcCtD
Glipizide—Feeling abnormal—Azathioprine—Crohn's disease	0.00028	0.0042	CcSEcCtD
Glipizide—Insomnia—Mesalazine—Crohn's disease	0.00028	0.00419	CcSEcCtD
Glipizide—Paraesthesia—Mesalazine—Crohn's disease	0.000277	0.00416	CcSEcCtD
Glipizide—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000277	0.00416	CcSEcCtD
Glipizide—Dyspnoea—Mesalazine—Crohn's disease	0.000276	0.00413	CcSEcCtD
Glipizide—Somnolence—Mesalazine—Crohn's disease	0.000275	0.00412	CcSEcCtD
Glipizide—Dyspepsia—Mesalazine—Crohn's disease	0.000272	0.00408	CcSEcCtD
Glipizide—Decreased appetite—Mesalazine—Crohn's disease	0.000269	0.00403	CcSEcCtD
Glipizide—Abdominal pain—Azathioprine—Crohn's disease	0.000268	0.00402	CcSEcCtD
Glipizide—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000267	0.004	CcSEcCtD
Glipizide—Constipation—Mesalazine—Crohn's disease	0.000264	0.00397	CcSEcCtD
Glipizide—Pain—Mesalazine—Crohn's disease	0.000264	0.00397	CcSEcCtD
Glipizide—Feeling abnormal—Mesalazine—Crohn's disease	0.000255	0.00382	CcSEcCtD
Glipizide—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000253	0.00379	CcSEcCtD
Glipizide—Hypersensitivity—Azathioprine—Crohn's disease	0.00025	0.00375	CcSEcCtD
Glipizide—Urticaria—Mesalazine—Crohn's disease	0.000246	0.00368	CcSEcCtD
Glipizide—Abdominal pain—Mesalazine—Crohn's disease	0.000244	0.00367	CcSEcCtD
Glipizide—Diarrhoea—Azathioprine—Crohn's disease	0.000232	0.00348	CcSEcCtD
Glipizide—Hypersensitivity—Mesalazine—Crohn's disease	0.000228	0.00342	CcSEcCtD
Glipizide—Dizziness—Azathioprine—Crohn's disease	0.000224	0.00337	CcSEcCtD
Glipizide—Asthenia—Mesalazine—Crohn's disease	0.000222	0.00333	CcSEcCtD
Glipizide—Pruritus—Mesalazine—Crohn's disease	0.000219	0.00328	CcSEcCtD
Glipizide—Vomiting—Azathioprine—Crohn's disease	0.000216	0.00324	CcSEcCtD
Glipizide—Eye disorder—Prednisone—Crohn's disease	0.000215	0.00323	CcSEcCtD
Glipizide—Rash—Azathioprine—Crohn's disease	0.000214	0.00321	CcSEcCtD
Glipizide—Dermatitis—Azathioprine—Crohn's disease	0.000214	0.00321	CcSEcCtD
Glipizide—Flushing—Prednisone—Crohn's disease	0.000214	0.0032	CcSEcCtD
Glipizide—Headache—Azathioprine—Crohn's disease	0.000213	0.00319	CcSEcCtD
Glipizide—Diarrhoea—Mesalazine—Crohn's disease	0.000211	0.00317	CcSEcCtD
Glipizide—Arrhythmia—Prednisone—Crohn's disease	0.000206	0.00308	CcSEcCtD
Glipizide—Dizziness—Mesalazine—Crohn's disease	0.000204	0.00307	CcSEcCtD
Glipizide—Nausea—Azathioprine—Crohn's disease	0.000202	0.00302	CcSEcCtD
Glipizide—Erythema—Prednisone—Crohn's disease	0.0002	0.00301	CcSEcCtD
Glipizide—Vomiting—Mesalazine—Crohn's disease	0.000196	0.00295	CcSEcCtD
Glipizide—Rash—Mesalazine—Crohn's disease	0.000195	0.00292	CcSEcCtD
Glipizide—Dermatitis—Mesalazine—Crohn's disease	0.000195	0.00292	CcSEcCtD
Glipizide—Headache—Mesalazine—Crohn's disease	0.000194	0.00291	CcSEcCtD
Glipizide—Vision blurred—Prednisone—Crohn's disease	0.000189	0.00283	CcSEcCtD
Glipizide—Ill-defined disorder—Prednisone—Crohn's disease	0.000186	0.00279	CcSEcCtD
Glipizide—Nausea—Mesalazine—Crohn's disease	0.000184	0.00275	CcSEcCtD
Glipizide—Malaise—Prednisone—Crohn's disease	0.000181	0.00271	CcSEcCtD
Glipizide—Vertigo—Prednisone—Crohn's disease	0.00018	0.0027	CcSEcCtD
Glipizide—Syncope—Prednisone—Crohn's disease	0.00018	0.0027	CcSEcCtD
Glipizide—Loss of consciousness—Prednisone—Crohn's disease	0.000176	0.00264	CcSEcCtD
Glipizide—Hypertension—Prednisone—Crohn's disease	0.000173	0.0026	CcSEcCtD
Glipizide—Myalgia—Prednisone—Crohn's disease	0.000171	0.00256	CcSEcCtD
Glipizide—Arthralgia—Prednisone—Crohn's disease	0.000171	0.00256	CcSEcCtD
Glipizide—Anxiety—Prednisone—Crohn's disease	0.00017	0.00255	CcSEcCtD
Glipizide—Discomfort—Prednisone—Crohn's disease	0.000169	0.00253	CcSEcCtD
Glipizide—Oedema—Prednisone—Crohn's disease	0.000164	0.00245	CcSEcCtD
Glipizide—Shock—Prednisone—Crohn's disease	0.000161	0.00241	CcSEcCtD
Glipizide—Hyperhidrosis—Prednisone—Crohn's disease	0.000158	0.00237	CcSEcCtD
Glipizide—Anorexia—Prednisone—Crohn's disease	0.000156	0.00234	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000149	0.00224	CcSEcCtD
Glipizide—Insomnia—Prednisone—Crohn's disease	0.000148	0.00222	CcSEcCtD
Glipizide—Paraesthesia—Prednisone—Crohn's disease	0.000147	0.0022	CcSEcCtD
Glipizide—Dyspepsia—Prednisone—Crohn's disease	0.000144	0.00216	CcSEcCtD
Glipizide—Decreased appetite—Prednisone—Crohn's disease	0.000142	0.00213	CcSEcCtD
Glipizide—Constipation—Prednisone—Crohn's disease	0.00014	0.0021	CcSEcCtD
Glipizide—Feeling abnormal—Prednisone—Crohn's disease	0.000135	0.00202	CcSEcCtD
Glipizide—Gastrointestinal pain—Prednisone—Crohn's disease	0.000134	0.00201	CcSEcCtD
Glipizide—Urticaria—Prednisone—Crohn's disease	0.00013	0.00195	CcSEcCtD
Glipizide—Abdominal pain—Prednisone—Crohn's disease	0.000129	0.00194	CcSEcCtD
Glipizide—Hypersensitivity—Prednisone—Crohn's disease	0.00012	0.00181	CcSEcCtD
Glipizide—Asthenia—Prednisone—Crohn's disease	0.000117	0.00176	CcSEcCtD
Glipizide—Pruritus—Prednisone—Crohn's disease	0.000116	0.00174	CcSEcCtD
Glipizide—Diarrhoea—Prednisone—Crohn's disease	0.000112	0.00168	CcSEcCtD
Glipizide—Dizziness—Prednisone—Crohn's disease	0.000108	0.00162	CcSEcCtD
Glipizide—Vomiting—Prednisone—Crohn's disease	0.000104	0.00156	CcSEcCtD
Glipizide—Rash—Prednisone—Crohn's disease	0.000103	0.00155	CcSEcCtD
Glipizide—Dermatitis—Prednisone—Crohn's disease	0.000103	0.00155	CcSEcCtD
Glipizide—Headache—Prednisone—Crohn's disease	0.000102	0.00154	CcSEcCtD
Glipizide—Nausea—Prednisone—Crohn's disease	9.71e-05	0.00146	CcSEcCtD
Glipizide—Gliclazide—ALB—Crohn's disease	2.05e-06	0.656	CrCbGaD
Glipizide—Glyburide—ALB—Crohn's disease	1.08e-06	0.344	CrCbGaD
